Voloridge Investment Management, LLC Eli Lilly & CO Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 94,000 shares of LLY stock, worth $73.2 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

94,000

Holding current value

$73.2 Million

% of portfolio

0.32%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $72.6 Million - $90.2 Million	94,000 New	94,000 $83.3 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $62.7 Million - $86.5 Million	144,269 Added 1086.04%	157,553 $84.6 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $37.1 Million - $49.6 Million	-105,755 Reduced 88.84%	13,284 $6.23 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $15.2 Million - $17.9 Million	49,044 Added 70.07%	119,039 $40.9 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $22.5 Million - $26.2 Million	69,995 New	69,995 $25.6 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $16.5 Million - $20.5 Million	-73,470 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $16.3 Million - $20 Million	73,470 New	73,470 $17 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $7.47 Million - $9.67 Million	-45,460 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $37.9 Million - $50.2 Million	-290,507 Reduced 86.47%	45,460 $7.68 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $21.4 Million - $24.8 Million	-146,598 Reduced 30.38%	335,967 $49.7 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $60.3 Million - $72.5 Million	441,846 Added 1085.11%	482,565 $79.2 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $11.5 Million - $14.2 Million	-96,197 Reduced 70.26%	40,719 $5.65 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $3.64 Million - $4.51 Million	-34,020 Reduced 19.9%	136,916 $18 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $8.14 Million - $8.85 Million	76,225 Added 80.48%	170,936 $19.1 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $10.5 Million - $12.2 Million	94,711 New	94,711 $10.5 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $795,421 - $936,268	-7,146 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $756,761 - $847,801	7,146 New	7,146 $827,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $12.9 Million - $15.2 Million	-173,732 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $1.37 Million - $1.47 Million	16,774 Added 10.69%	173,732 $14.7 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $12.1 Million - $13.4 Million	156,958	156,958 $13.4 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Eli Lilly & CO Transaction History